| # Changelog | |
| ## v0.1.3 | |
| - Expanded SEC-HPLC purity from 4 to **82 biosimilars**, from the full supplier CoA vault | |
| (coa.ichor.bio), with lot numbers and concentrations. | |
| - For 68 of them, recorded the **exact monomer %** read from the CoA chromatogram peak table | |
| (280 nm main peak), replacing the earlier ">95%" placeholder; the other 14 keep the CoA's | |
| >95%/≥95% specification where no chromatogram is provided. | |
| ## v0.1.2 | |
| - Added the first SEC-HPLC purity values from supplier Certificates of Analysis for 4 biosimilars | |
| (Selicrelumab, Farletuzumab, Bococizumab, Romosozumab). | |
| - Added a SEC-HPLC method (`M-SEC-HPLC`) and filled lot number + concentration on sample rows. | |
| ## v0.1.1 | |
| - Column and formatting cleanup of the antibodies table. | |
| - Set `expression_system` to `CHO` for all antibodies. | |
| ## v0.1.0 | |
| - Seed release: 480 antibodies with sequences + identity; 960 computed values (MW, theoretical pI). | |
| - Structure established (Antibodies/Samples/Methods/Measurements + data dictionary). | |